|
Project No. 034-17016
<br /> Site-Specific Health& Safety Plan
<br /> Page No. 19
<br /> TABLE 1(cont.)
<br /> SUMMARY OF CONSTITUENTS OF CONCERN—SSI LATHROP
<br /> Constituent of Concern OSHA Route Symptoms of Target Organs
<br /> PEL/STEL/TWA of Exposure
<br /> (PPMV) Entry
<br /> METALS CONT.
<br /> Barium, soluble compounds as 0.5 mg/m3/- Ing, Irritation of resp. Eyes,skin, resp.
<br /> (Ba) Ing, sys, skin,eyes; sys.,heart,CNS
<br /> Skin, muscle spasms,
<br /> Eyes vomiting,
<br /> abdominal
<br /> cramps, diarrhea,
<br /> slow pulse,
<br /> unconsciousness,
<br /> respiratory arrest
<br /> Chromium 0.5 mg/m'/- Ing, Irritation to skin Eyes, skin,
<br /> Inh, and respiratory respiratory system
<br /> Skin tract
<br /> Chromium(VI) 0.005 mg/m'/- Inh, Irritation to skin Eyes, skin,resp. sys.
<br /> Ing, and respiratory
<br /> Skin tract
<br /> Cobalt 0.1 mg/m3/- Inh, Cough,difficulty Skin, resp. sys.
<br /> (NIOSH 0.05 Ing, breathing,
<br /> mg/m3) Eyes, decreased
<br /> Skin pulmonary
<br /> function,weight
<br /> loss,dermatitis
<br /> Copper 0.1 mg/m3/- Inh, Irritation eyes, Eyes,skin,resp. sys.
<br /> Skin, resp. sys.;chills,
<br /> Eyes muscle ache,
<br /> nausea, fever, dry
<br /> throat,cough,
<br /> discoloration skin
<br /> or hair,
<br /> weakness,
<br /> exhaustion
<br /> Lead 0.050 mg/m'/- Inh, Al distress, Eyes,GI tract, CHS,
<br /> Ing kidney failure, kidneys, blood,
<br /> weakness, gingival tissue
<br /> insomnia,
<br /> constipation,
<br /> abdominal pain
<br /> Mercury 0.01 mg/m3/ Inh, Irritation to eyes, Eyes,skin,resp.
<br /> Ceiling 0.04 mg/m3 Ing, skin, cough, chest sys., CNS,kidneys
<br /> (NIOSH: Eyes, pain,pneumonitis
<br /> vapor/skin 0.1 Skin
<br /> mg/cubic meter)
<br /> (NIOSH:
<br /> ceiling/skin .03
<br /> m m3
<br /> KRAZAN&ASSOCIATES,INC.
<br /> With Offices Serving the Western United States
<br /> 03417016 SSI Lathrop}LISP Finel.doc
<br />
|